Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | NNNNAnbio BiotechnologyFY2025 · Dec |
|---|---|
| Revenue | $8.65M |
| Revenue, yoy | +5.6% |
| Net income | $6.40M |
| Net income, yoy | +169.9% |
| Net margin | 74.1% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.15 |
Add another company.